Lundbeckfonden Ventures is an evergreen venture fund with a portfolio of approx. 20 life science companies primarily in Europe and the USA. The Ventures team counts on extensive international and operational experience.
Lundbeckfonden Emerge is the early-stage investment unit of the Foundation, established to identify and invest in small biotech companies based on pioneering Danish-based research with commercial potential.
Our investment team manages the Foundation’s available funds of around DKK 16bn corresponding to around 25% of our assets. The purpose is to generate returns and secure sufficient reserves to support the Foundation’s grant activities and the subsidiaries.
The Brain Prize is the world’s largest international research prize within neuroscience. It honours ground-breaking research and spearheads the Lundbeck Foundation’s ambition to make Denmark one of the leading brain research nations of the world.
The science we support is innovative. So is our way of thinking and working. We have the curiosity to explore new opportunities, the drive to find the best approach, and the courage to break new grounds.
Our business relies on strong relations with the companies we invest in, the scientists we support, and the partners and colleagues we work with. Strong relations are nurtured by respect.
We are ambitious people who truly want to make a difference. We set high standards and put in the energy to meet them. Dedication leads to great results and creates value.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.